BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17349694)

  • 1. Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.
    Fuller CL; Brittingham KC; Porter MW; Hepburn MJ; Petitt PL; Pittman PR; Bavari S
    Mol Immunol; 2007 May; 44(12):3173-84. PubMed ID: 17349694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.
    Ryden P; Twine S; Shen H; Harris G; Chen W; Sjostedt A; Conlan W
    Mol Immunol; 2013 May; 54(1):58-67. PubMed ID: 23201853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
    Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
    Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tularaemia vaccine.
    Sandström G
    J Chem Technol Biotechnol; 1994 Apr; 59(4):315-20. PubMed ID: 7764815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
    Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB;
    Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of human immune responses to
    Lindgren H; Eneslätt K; Golovliov I; Gelhaus C; Sjöstedt A
    Front Immunol; 2023; 14():1238391. PubMed ID: 37781364
    [No Abstract]   [Full Text] [Related]  

  • 11. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy.
    De Pascalis R; Mittereder L; Kennett NJ; Elkins KL
    Infect Immun; 2016 Apr; 84(4):1054-1061. PubMed ID: 26810039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.
    Schmitt DM; O'Dee DM; Horzempa J; Carlson PE; Russo BC; Bales JM; Brown MJ; Nau GJ
    PLoS One; 2012; 7(2):e31172. PubMed ID: 22355343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison.
    Rohmer L; Brittnacher M; Svensson K; Buckley D; Haugen E; Zhou Y; Chang J; Levy R; Hayden H; Forsman M; Olson M; Johansson A; Kaul R; Miller SI
    Infect Immun; 2006 Dec; 74(12):6895-906. PubMed ID: 17000723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
    Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).
    Twine SM; Petit MD; Fulton KM; House RV; Conlan JW
    PLoS One; 2010 Apr; 5(4):e10000. PubMed ID: 20368994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of protective immunity to Francisella tularensis.
    Tärnvik A
    Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis.
    Bradburne CE; Verhoeven AB; Manyam GC; Chaudhry SA; Chang EL; Thach DC; Bailey CL; van Hoek ML
    J Biol Chem; 2013 Apr; 288(15):10780-91. PubMed ID: 23322778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.